Abstract:Background: Australian federally-funded cognitive pharmacy services (CPS) (e.g. medication management and reconciliation services) have not been translated into practice consistently. These health services are purportedly accessible across all Australian community pharmacies, yet are not delivered as often as pharmacists would like. There are international indicators that pharmacists lack the complete behavioural control required to prioritise CPS, despite their desire to deliver them. This requires local investigation. Objective: To explore Australian pharmacists' perspectives [1] as CPS providers on the micro level, and [2] on associated meso and macro level CPS implementation issues. Methods: Registered Australian community pharmacists were recruited via professional organisations and snowball sampling. Data were collected via an online demographic survey and semi-structured interviews until data saturation was reached. Interview transcripts were de-identified then verified by participants. Content analysis was performed to identify provider perspectives on the micro level. Framework analysis using RE-AIM was used to explore meso and macro implementation issues. Results: Twenty-three participants across Australia gave perspectives on CPS provision. At the micro level, pharmacists did not agree on a single definition of CPS. However, they reported complexity in interactional work and patient considerations, and individual pharmacist factors that affected them when deciding whether to provide CPS. There was an overall deficiency in pharmacy workplace resources reported to be available for implementation and innovation. Use of an implementation evaluation framework suggested CPS implementation is lacking sufficient structural support, whilst reach into target population, service consistency and maintenance for CPS were not specifically considered by pharmacists. Conclusions: This analysis of pharmacist CPS perspectives suggests slow uptake may be due to a lack of evidence-based, focused, multi-level implementation strategies that take ongoing pharmacist role transition into account. Sustained change may require external change management and implementation support, engagement of frontline clinicians in research, and the development of appropriate pharmacist practice models to support community pharmacists in their CPS roles. Trial registration: This study was not a clinical intervention trial. It was approved by the University of Technology Sydney Human Research Ethics Committee (UTS HREC 19-3417) on the 26th of April 2019.

Prescription drug monitoring program in Australia: a qualitative study of stakeholders' experiences and perceptions of a state-wide implementation

Association of state‐level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia

"Nobody Knows How You're Supposed to Interpret it:" End-user Perspectives on Prescription Drug Monitoring Program in Massachusetts

Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study

The importance of data source in prescription drug monitoring program research

Online reporting of pseudoephedrine pharmacy sales: does Australia require a mandatory system?

Electronic health records and e-prescribing in Australia: An exploration of technological utilisation in Australian community pharmacies

Considerations of Australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study

Development of pharmacy-based best practices to support safer use and management of prescription opioids based on an e-Delphi methodology

Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation

Association between prescription drug monitoring programs use mandates and prescription stimulants received by Medicaid enrollees

Increased prevalence of pentylone and dipentylone in combination with other drugs in New South Wales, Australia

Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand

Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders' views on implementation of a novel pharmacy regulator mandated preceptorship model

State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009-2020

Would they accept it? An interview study to identify barriers and facilitators to user acceptance of a prescribing advice service

Prescription Drug Monitoring Program Use: National Dental PBRN Results

Medication management issues perceived by pharmacists and disability caregivers while supporting people with disability

Implementing pharmacogenomic testing in Australian general practice: an exploratory qualitative study

Development of an antimicrobial stewardship implementation model involving collaboration between general practitioners and pharmacists: GPPAS study in Australian primary care

The Australian Team Approach to Polypharmacy Evaluation and Reduction (AusTAPER) hospital study: effect of a collaborative medication review on the number of current regular medicines for older hospital inpatients